Jesús
Barreiro Conde
Novo Nordisk
Copenhagen, DinamarcaPublications in collaboration with researchers from Novo Nordisk (1)
2017
-
Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial
Clinical Endocrinology, Vol. 87, Núm. 4, pp. 350-358